"Today’s work, tomorrow’s possibility."
to Rupert Swift
Registration now open
The world's leading learning course in pulmonary vascular disease
Through worldwide collaboration, we can begin to answer the question of a global disease.
Second impact factor announced of 2.283. Congratulations to the Editorial Team.
Our members range from post-doctoral students, to the world’s leading cardiologists, pharmacologists and physicians.
Director, Bluhm Cardiovascular institute Pulmonary Vascular Disease Program. Northwestern University
United States
""
Professor of Pulmonary Pharmacology University of Glasgow
United Kingdom
Postdoc ECCPS, University Giessen
Germany
We inform and educate the world about PVD through our learning materials and publications
We enable our members to collaborate through our bi-annual conferences.
Our Task Forces throughout the world combat the disease first hand in over 60 countries and specialise in 8 forms of PVD.
All in one place.
